Interleukin-23 Involved in Fibrotic Autoimmune Diseases: New Discoveries

J Clin Med. 2023 Sep 1;12(17):5699. doi: 10.3390/jcm12175699.

Abstract

Interleukin (IL)-23 is a central pro-inflammatory cytokine with a broad range of effects on immune responses. IL-23 is pathologically linked to the induction of the production of the pro-inflammatory cytokines IL-17 and IL-22, which stimulate the differentiation and proliferation of T helper type 17 (Th17) cells. Recent discoveries suggest a potential pro-fibrotic role for IL-23 in the development of chronic inflammatory autoimmune diseases characterized by intense fibrosis. In this review, we summarized the biological features of IL-23 and gathered recent research on the role of IL-23 in fibrotic autoimmune conditions, which could provide a theoretical basis for clinical targeting and drug development.

Keywords: IL-23; autoimmunity; fibrosis; inflammation.

Publication types

  • Review

Grants and funding

This research received no external funding.